Author Archives: PharmAust

Stable Patient in MND trial reaches 6-months on MPL

Stable Patient in MND trial reaches 6-months on MPL

Canine Cancer Trial Update

Canine Cancer Trial Update

First Patient of Cohort 2 Dosed in MND Trial 3 market sensitive

First Patient of Cohort 2 Dosed in MND Trial (final)

PharmAust canine trial update 18 market sensitive

PharmAust canine trial update Feb (final)

Appendix 4C and Quarterly Update

Appendix 4C and Quarterly Update – Dec 22

PharmAust Progresses to Elevated Doses in MND Patients

PharmAust Progresses to Elevated Doses of MPL in MND Patients

Fireside chat with Dr Roger Aston

https://www.pharmaust.com/wp-content/uploads/2023/01/Fireside-chat-with-Roger.mp4